SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,231.00    7.00 (0.57%)
Bid:
1,229.00
Ask:
1,230.00
Spread: 1.00 (0.081%)
Market Cap: £858.56m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisition

16 Mar 2010 07:00

RNS Number : 6217I
CVS Group plc
16 March 2010
 



 

CVS Group plc ("CVS" or the "Company")

16 March 2010

Acquisition of veterinary surgery

CVS, one of the UK's leading providers of veterinary services, is pleased to announce the acquisition of Goudhurst Veterinary Surgery and Equine clinic ("Goudhurst"), a single site veterinary surgery based in Kent.

The acquisition demonstrates the Company's strong pipeline of potential acquisition opportunities following the acquisition of Veterinary Enterprises and Trading Limited ("Veterinary Enterprises") earlier this month and increases the number of surgeries operated by CVS to 198.

CVS will assume all management responsibilities for Goudhurst following completion of the acquisition. In line with the Company's strategy, administration will be consolidated within the Company's central facilities, providing cost synergies and benefits following the acquisition.

In the year ended 31 March 2009, Goudhurst achieved profit before tax of GBP109,000 on turnover of approximately GBP503,000. The acquisition includes GBP43,000 of fixed assets at the March 2009 year end and CVS will also acquire the current stock. The consideration for the acquisition is being met entirely from internally generated cash. The practice has three professional vets and nine staff in total.

Commenting on the acquisition, CVS Chief Executive Simon Innes said: "Goudhurst is a quality well established practice and we are delighted to be continuing to add to our portfolio immediately following the completion of the acquisition of Veterinary Enterprises earlier this month. We look forward to working with the Goudhurst team to help them continue the high level of animal care and customer service that they have been delivering to date."

For further enquiries please contact:

CVS Group plc

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

Brewin Dolphin Investment Banking

Richard Jones/Matt Davis

Paul Mason

0845 059 6740

Buchanan Communications

Richard Oldworth

Suzanne Brocks

020 7466 5000

Ends

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLFFLIVDIELII
Date   Source Headline
12th Jun 202611:08 amRNSHolding(s) in Company
12th Jun 202610:06 amRNSHolding(s) in Company
8th Jun 20262:43 pmRNSStandard form for notification of major holdings
8th Jun 20262:41 pmRNSUpdated: Transaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTotal Voting Rights
28th May 20267:00 amRNSPDMR Dealing
26th May 20267:02 amRNSChanges to NEDs' Responsibilities
26th May 20267:01 amRNSCommencement of Share Buyback Programme
26th May 20267:00 amRNSRefinancing, Launch of SBB and Acquisition
8th May 20263:55 pmRNSStandard form for notification of major holdings
30th Apr 20267:00 amRNSTotal Voting Rights
21st Apr 202612:46 pmRNSNon-Executive Director Appointment
20th Apr 20264:45 pmRNSStandard form for notification of major holdings
31st Mar 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSCEO retirement
25th Mar 20267:00 amRNSNon-Executive Director Changes
24th Mar 20267:13 amRNSResponse to CMA Summary Final Decision Report
27th Feb 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSInterim Results
30th Jan 20267:00 amRNSTotal Voting Rights
29th Jan 20262:02 pmRNSStandard form for notification of major holdings
29th Jan 20268:00 amRNSReadmission - CVS Group Plc
29th Jan 20267:00 amRNSAdmission to Trading on the Main Market of the LSE
28th Jan 20267:08 amRNSResponse to DEFRA consultation
27th Jan 20262:31 pmRNSStandard form for notification of major holdings
23rd Jan 202612:19 pmRNSPublication of Prospectus and Trading Update
23rd Jan 20267:00 amRNSProgramme completion and transaction in own shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20269:51 amRNSStandard form for notification of major holdings
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20264:24 pmRNSStandard form for notification of major holdings
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSBlock Listing Interim Review
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20264:31 pmRNSStandard form for notification of major holdings
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20269:34 amRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.